This is a joint meeting with representatives from patients’, consumers’ and healthcare professionals’ organisations. The participants are discussing issues in relation to their general involvement in the Agency’s activities, giving particular focus to the new pharmacovigilance legislation, communication and information. Registration by invitation only.
Go to Source

This entry was posted on Tuesday, September 25th, 2012 at 3:00 pm and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.